Provaxa
Preclinical Studies
Accelerating Discovery. Advancing Therapies.
Comprehensive preclinical research solutions from in vitro and in vivo studies to toxicology and regulatory compliance, accelerating your path to clinical development.
Preclinical Research Excellence
Advanced capabilities through approved vendor partnerships and expert oversight
Your Partner in Early-Stage Drug Development
Preclinical trials are essential early-stage studies that evaluate the safety, efficacy, and pharmacological properties of new drug candidates before clinical trials in humans. At Provaxa, we accelerate drug development by leveraging advanced capabilities of industry-approved preclinical research vendors, ensuring clients receive reliable and actionable data to drive informed decisions in therapeutic development.
Through our collaborative vendor alliance, we provide expertise, advanced technology, and comprehensive regulatory support. Our integrated preclinical offerings support every stage of drug development, from in vitro and in vivo studies to pharmacokinetic and toxicology assessments, delivering high-quality, compliant data that serves as the foundation for regulatory submissions and clinical study progression.
We help pharmaceutical companies generate reliable preclinical data, reduce development costs, and accelerate pathways to clinical testing while ensuring full compliance with Good Laboratory Practice (GLP) standards and regulatory requirements.
Why Preclinical Studies Matter
Preclinical studies generate essential safety and efficacy data that regulatory agencies require before approving human clinical trials. This phase ensures drugs meet compliance standards, identifies potential risks early, validates therapeutic targets, and accelerates the transition from discovery to clinical development, ultimately reducing development timelines and increasing the likelihood of regulatory approval.
GLP Capabilities & Services
Comprehensive preclinical study solutions across all phases of drug development
In Vitro & In Vivo Efficacy & Safety Studies
Comprehensive laboratory and animal testing to evaluate drug candidate safety and efficacy. Our network of GLP-compliant vendor partners conducts rigorous assessments using validated models and methodologies aligned with regulatory expectations.
- Cell-based assays and tissue models
- Animal model efficacy studies
- Safety assessment and tolerability evaluation
- Multi-species safety testing protocols
- GLP-compliant study conduct and reporting
- Quality assurance and audit readiness
Pharmacokinetics & Pharmacodynamics (ADME/PK)
Advanced research to understand how drugs behave in the body. We assess absorption, distribution, metabolism, excretion (ADME) and pharmacodynamic properties to optimize dosing strategies and predict clinical efficacy.
- ADME studies and bioavailability assessment
- Pharmacokinetic profiling across species
- Drug-drug interaction studies
- Pharmacodynamic target engagement
- Metabolite characterization
- Predictive modeling and analysis
Drug Formulation Development & Optimization
Scientific design and optimization of drug formulations to improve delivery, stability, and bioavailability. We support the transition from laboratory compounds to clinically viable formulations ready for human testing.
- Formulation strategy and optimization
- Delivery system development
- Stability testing and shelf-life assessment
- Scale-up support for manufacturing
- Bioavailability enhancement
- Regulatory-compliant documentation
Toxicology Testing & Risk Assessment
Comprehensive evaluation of potential risks and adverse effects associated with drug candidates. Our toxicology studies assess organ-system toxicity, genotoxicity, and other critical safety parameters required for regulatory approval.
- Acute and repeat-dose toxicity studies
- Organ system toxicity assessment
- Genotoxicity and carcinogenicity screening
- Reproductive and developmental toxicity
- Safety pharmacology evaluations
- GLP-compliant toxicology reports
Custom Assay Development & Model Generation
Tailored development of specialized assays and disease models specific to your therapeutic target. We collaborate with vendors to create innovative experimental approaches that differentiate your program and accelerate drug discovery.
- Custom assay design and validation
- Disease-specific model development
- Biomarker identification and measurement
- High-throughput screening support
- Translational model development
- Method validation and documentation
Regulatory Support & Documentation
Expert guidance on preclinical data requirements for regulatory submissions. We ensure your studies align with ICH, FDA, EMA, and CDSCO guidelines, preparing comprehensive documentation for seamless transition to clinical development.
- Study design alignment with regulatory guidelines
- Good Laboratory Practice (GLP) compliance
- Preclinical data compilation and analysis
- Investigational New Drug (IND) dossier support
- Protocol development and review
- Regulatory consultation and submissions
Commitment to Quality & Collaboration
Vetted vendor partnerships and rigorous oversight ensuring scientific excellence
Vendor Excellence & Oversight
At Provaxa, we partner exclusively with thoroughly vetted preclinical research vendors who demonstrate regulatory compliance, scientific rigor, and proven reliability. Our vendor selection process is rigorous, ensuring all partners meet stringent quality standards and maintain ISO-certified operations.
We maintain close collaboration with our vendor partners throughout every project phase, from study design and protocol development to final reporting. This integrated approach ensures transparency, maintains scientific integrity, and provides seamless communication between your team and the research facility. We serve as your single point of contact for all preclinical activities, simplifying project management and accelerating timelines.
Our in-house Quality Assurance team conducts regular audits to ensure that all preclinical study activities, vendor processes, and investigational protocols are fully compliant with regulatory requirements, company standards, and GLP guidelines. This maintains data integrity, supports regulatory acceptance, and ensures operational excellence throughout every phase of your preclinical program.
Our Vendor Partner Network
Our collaborative alliance includes industry-leading preclinical research organizations offering:
- State-of-the-art laboratory infrastructure and equipment
- Specialized scientific expertise across therapeutic areas
- GLP-compliant study conduct and documentation
- Advanced analytical capabilities and technologies
- Rapid turnaround times and flexible project scaling
- Transparent reporting and collaborative communication
Quality Assurance Excellence
Provaxa's dedicated QA team ensures rigorous oversight at every stage:
- Pre-Study Audits: Protocol review, vendor capability assessment, and compliance verification
- On-Site Monitoring: Regular facility inspections and process oversight
- Data Integrity Checks: Verification of study conduct, data collection, and analysis
- Post-Study Review: Final report validation and regulatory readiness assessment
- Continuous Improvement: Feedback integration and process optimization
ISO-Certified Quality Systems
Our ISO-certified quality systems and proven compliance record ensure your preclinical program meets all regulatory expectations. We maintain detailed audit trails, comprehensive documentation, and robust quality control measures to support regulatory submissions with confidence and accelerate your path to clinical development.
Accelerate Your Preclinical Program
Partner with Provaxa for comprehensive preclinical research services that deliver high-quality data, regulatory compliance, and rapid advancement to clinical development.